HD-OPM Archive
Topics › Blood vessels, circulation & endothelium

Chelation therapy for heart disease: TACT showed some signal, TACT2 did not confirm it

Louis Nervegna · Mar 22, 2026 · ♥ 3 reactions · 1 comments · original Facebook post
Blood vessels, circulation & endotheliumHeart attack, stroke & procedures
AI summary & key facts

Louis quotes Mayo Clinic on EDTA chelation. The TACT trial found no support for routine use but a possible benefit in people with diabetes and prior heart attack; the follow-up TACT2 in that group did not show lower risk of heart attack, stroke or related events.

Chelation therapy for heart disease: Does it work?

Quoted:

Chelation therapy involves weekly treatments of medicine called ethylenediaminetetraacetic acid, also known as EDTA. The medicine is given through a vein. Each treatment lasts from 30 minutes to up to a few hours.

The medicine finds and sticks to metals and minerals in the bloodstream. This action forms a substance that works its way through the body and leaves in the urine. Some early researchers thought that EDTA might stick to and remove calcium found in plaque buildups that clog arteries. That's why they thought chelation therapy could treat heart disease.

But recent research suggests otherwise. Here's what is known so far:

mayoclinic.orgLink to mayoclinic.orgmayoclinic.org

#chelationHD #tactHD #tact2HD #mayoclinicHD #edtaHD

Research cited

← newer: How metformin works beyond lowering blood sugarolder: Statins, ezetimibe and PCSK9 inhibitors reverse plaque once →